Bibliography
Found 96 results
Filters: Author is Letendre, Scott L [Clear All Filters]
Neurologic complications of HIV disease and their treatment. Topics in HIV Medicine: A Publication of the International AIDS Society, USA [Internet]. 2007 ;15:32-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17485785
. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. The Journal of Infectious Diseases [Internet]. 2007 ;196:361-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17597450
Variable patterns of neuropsychological performance in HIV-1 infection. Journal of Clinical and Experimental Neuropsychology [Internet]. 2008 ;30:613-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18608689
. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693
Low atazanavir concentrations in cerebrospinal fluid. AIDS. 2009 ;23(1):83-7.
Proteomic fingerprints in CSF and blood of HIV-infected patients with neurocognitive disorders. In: The 9th International Symposium on NeuroVirology. The 9th International Symposium on NeuroVirology. Miami Beach, FL; 2009.
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.
Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011 ;17(3):248-57.
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.
Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother. 2011 ;66(2):354-7.
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 ;17(1):3-16.
Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 ;17(1):50-7.
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.
Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr. 2012 ;59(4):376-81.
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. Journal of NeuroVirology [Internet]. 2013 ;19(1):89-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23341224
Alterations in the levels of vesicular trafficking proteins involved in HIV replication in the brains and CSF of patients with HIV-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology [Internet]. 2013 ;8(5):1197-1209. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24292993
. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.
. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Editorial commentary: Severe HIV-associated CD8+ T-cell encephalitis: is it the tip of the Iceberg?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America [Internet]. 2013 ;57:109-11. Available from: https://www.ncbi.nlm.nih.gov/m/pubmed/23515206/?i=1&from=/23515206/related
. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Global NeuroAIDS roundtable. J Neurovirol. 2013 ;19(1):1-9.
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.